𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver transplantation for severe intrahepatic noncirrhotic portal hypertension

✍ Scribed by Alyssa M. Krasinskas; Bijan Eghtesad; Patrick S. Kamath; Anthony J. Demetris; Susan C. Abraham


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
356 KB
Volume
11
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


Intrahepatic noncirrhotic portal hypertension can be idiopathic or associated with known toxic, developmental, vascular, or biliary tract diseases. Most patients are successfully managed medically or with shunting procedures. The goal of this study was to explore the reasons some patients require orthotopic liver transplantation (OLT). The clinical features, gross and microscopic liver explant pathology, and posttransplantation course in 16 patients who underwent OLT for intrahepatic noncirrhotic portal hypertension were studied. There were 11 men and 5 women with a mean age of 47 years. Clinical manifestations included gastrointestinal varices (n = 12), ascites (n = 8), encephalopathy (n = 3), and hepatopulmonary syndrome (n = 3). Cirrhosis was misdiagnosed clinically, radiographically and/or histologically in 13 patients (81%). Grossly, liver explants weighed a mean of 1,100 g, and 12 had a nodular appearance. Histologically, all 16 livers had portal tract vascular abnormalities, 15 had nodular regenerative hyperplasia (NRH), and 9 had incomplete septal cirrhosis. After OLT, mild NRH features were noted in 2 patients, and 1 of these patients developed evidence of portal hypertension. This study demonstrates that a subset of patients with intrahepatic noncirrhotic portal hypertension have severe symptoms requiring OLT. Accurate pre-OLT diagnosis is frequently difficult at advanced stages of the disease; 81% of our patients carried a diagnosis of cirrhosis. Morphologically, the explanted livers showed evidence of vascular abnormalities, NRH, and increased fibrosis, but not cirrhosis. Importantly, however, a diagnosis of cirrhosis is not required in this group of patients to qualify them for OLT, and these patients have good long-term graft function after OLT.


πŸ“œ SIMILAR VOLUMES


Idiopathic noncirrhotic intrahepatic por
✍ Ashish Goel; Banumathi Ramakrishna; Kadiyala Madhu; Uday Zachariah; Jeyamani Ram πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 209 KB

We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong

Histopathological study of intrahepatic
✍ Makoto Ohbu; Masahiko Okudaira; Kiyoharu Watanabe; Satoshi Kaneko; Tomoko Takai πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 777 KB

Aberrant vessels, which are defined as dilated blood vessels immediately adjacent to the peripheral portal tract, appear under conditions of extrahepatic portal obstruction and nodular regenerative hyperplasia as well as idiopathic portal hypertension. Our study was

Intrahepatic portal cavernoma as an indi
✍ Cristina H. Hajdu; Takahiro Murakami; Thomas Diflo; Bachir Taouli; Jordan Laser; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 324 KB

Cavernous transformation of the portal vein (portal cavernoma) consists of a periportal or/and intrahepatic venous collateral network, developed as a result of acute or long-standing portal vein thrombosis. Better control of hemorrhagic and thrombotic complications in the patients with portal cavern

Endothelin-1 modulates intrahepatic resi
✍ Patrick S. Kamath; Gertrude M. Tyce; Virginia M. Miller; Brooks S. Edwards; Duan πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 409 KB

Factors that increase resistance to blood flow through the hepatic sinusoids when portal hypertension occurs in the absence of significant hepatic fibrosis are not completely understood. Experiments were designed to test the hypothesis that endothelin-1 (ET-1) is one of the humoral factors that incr

Noncirrhotic presinusoidal portal hypert
✍ Peter Witters; Louis Libbrecht; Tania Roskams; Kris De Boeck; Lieven Dupont; Mar πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.